Vyome Holdings, Inc. (HIND) vs Pasithea Therapeutics Corp. (KTTA)
A side-by-side comparison of Vyome Holdings, Inc. and Pasithea Therapeutics Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HIND
Vyome Holdings, Inc.
$1.95HealthcareDelayed quote: Oct 6, 2026, 12:40 PM EDT
KTTA
Pasithea Therapeutics Corp.
$0.45HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Total return — HIND vs KTTA
growth of $100 · dividends reinvested · last 5yHIND -100.0% (-93.1%/yr)KTTA -99.4% (-63.6%/yr)KTTA compounded faster over this window
Log scale — wide-divergence pair
HIND KTTA
HIND vs KTTA: by the numbers
- •KTTA is the larger company ($15M vs $14M market cap).
- •Both run net losses; KTTA's is the smaller (0.00% vs -8716.77% net margin).
Metrics side by side
Valuation
| Metric | HIND | KTTA |
|---|---|---|
| P/S ratio | 105.27 | N/A |
| P/B ratio | 2.26 | 0.30 |
| FCF yield | 3.84% | N/A |
Profitability
| Metric | HIND | KTTA |
|---|---|---|
| Gross margin | 64.68% | 0.00% |
| Operating margin | -859.22% | 0.00% |
| Net margin | -8716.77% | 0.00% |
| ROE | -186.95% | -42.72% |
| ROIC | -57.53% | -48.04% |
Growth (annualized)
| Metric | HIND | KTTA |
|---|---|---|
| Revenue CAGR (5Y) | -60.54% | N/A |
| Total return CAGR (5Y) | -92.93% | -61.48% |
Frequently asked
- How have HIND and KTTA total returns compared?
- Over the past 5 years, HIND delivered -92.93% and KTTA delivered -61.48% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.